All Type of News
“It is inappropriate to display ‘atopy or atopic’ in cosmetics advertising”
When it came to the usage of the term, ‘atopy,’ in cosmetics wrapping papers and advertisements, the health care industry have expressed concerns.
The Ministry of Food and Drug Safety has recently given an administra...
Ilyang Pharm advances to the global market with leukemia treatment, ‘Supect’Ilyang Pharm(CEO Dong-yun Kim) attracted interest of the global market as announcing 3 results of the final clinical trial of the Asia’s first leukemia treatment, ‘Supect(generi...
|
Accelerated growth of blood glucose monitoring devices
Growth of blood glucose monitoring devices is forecasted to continue.
The Medical Device Industry Support Group of the Korea Health Industry Development Institute(KHIDI) announced demands for blood glucose monitoring...
This year’s pharmaceutical sales records KRW 12.6 trillion increasing 3.4% up
This year, pharmaceutical sales were forecasted to increase 3.4% up over the last year and record KRW 12.6 trillion.
Shinhan Investment Corp., recently, forecasted pharmaceutical sales will be KRW 12.6 trillion and p...
Yuhan tops KRW 1.1 trillion, Green Cross and Hanmi are likely to achieve KRW 1 Trillion Club
The top pharmaceutical trios of the year are most likely to achieve the 1 Trillion Club. Yuhan Corporation, which exceed KRW 1 trillion sales for the first time, is sure to record KRW 1.1 trillion keeping the upturn.
...
Emergence of blockbuster-level obesity drug, but Furing and Xenical decrease narrowly
It was the year that the market has shown enormous interests on newly-launched obesity treatments after a long time.
Belviq, which acquired FDA’s approval in 13 years, has suddenly became a leading product as introdu...
Samsung Bioepis acquires domestic product approval of ‘Renflexis’
Samsung Bioepis announced acquisition of product approval of Renflexis(Remicade biosimilar), an autoimmune disease treatment, from the Ministry of Food and Drug Safety on the 4th.
Thus, Samsung Bioepis has become a c...
Pharmaceutical distribution industry to focus on improving low margins of multinational pharmaceutical companies
The pharmaceutical distribution industry will continue the promotional activities to improve low-margin policies of multinational pharmaceutical companies next year.
The Seoul Pharmaceutical Distribution Association(...
Novartis informs Early Retirement Program to layoff staffs in 2 yearsNovartis Korea will start the Early Retirement Program(ERP).
According to the industry concerned, Novartis has suggested target departments and conditions with the ERP announce...
|
Cinfa establishes distribution agreement with DKSH expanding domestic healthcare business
Laboratorios Cinfa and DKSH Korea, a multinational logistics company, established a strategic agreement.
Under the agreement, Cinfa will sell leading products of ‘Farmalastic,’ its medical equipment brand, through th...
